Deep Dive Into HOOKIPA Pharma Stock: Analyst Perspectives (4 Ratings)
Deep Dive Into HOOKIPA Pharma Stock: Analyst Perspectives (4 Ratings)
深入了解HOOKIPA製藥股票：分析師觀點（4個評級）
HOOKIPA Pharma (NASDAQ:HOOK) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
HOOKIPA Pharma（納斯達克股票代碼：HOOK）在上個季度接受了4位分析師的分析，揭示了從看漲到看跌的一系列觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.38, along with a high estimate of $6.50 and a low estimate of $5.00. A decline of 17.23% from the prior average price target is evident in the current average.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲5.38美元，最高估計爲6.50美元，低估值爲5.00美元。目前的平均價格比先前的平均目標股價下降了17.23％。
Decoding Analyst Ratings: A Detailed Look...
解碼分析師評...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。